Bayesian statistical method was underused despite its advantages in the assessment of implantable medical devices

Journal of Clinical Epidemiology

Volumn 64, Issue 3, 2011, Pages 270-279

  Pibouleau, Leslie ^a,b,c   Chevret, Sylvie ^a,b,c  

^a INSERM   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Bayesian methods; Clinical trials; Health technology assessment; Implantable; medical devices; Prior elicitation; ROBUST checklist

Indexed keywords

BAYES THEOREM; BIOMEDICAL TECHNOLOGY ASSESSMENT; CLINICAL RESEARCH; CLINICAL STUDY; DEVICE; HUMAN; IMPLANT; MEDICAL INSTRUMENTATION; META ANALYSIS (TOPIC); OUTCOME ASSESSMENT; PRIORITY JOURNAL; PRODUCT SAFETY; REVIEW; SYSTEMATIC REVIEW;

BAYES THEOREM; BIAS (EPIDEMIOLOGY); CLINICAL TRIALS AS TOPIC; COST-BENEFIT ANALYSIS; HUMANS; META-ANALYSIS AS TOPIC; PROSTHESES AND IMPLANTS;

EID: 78751643611     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2010.03.018     Document Type: Review

References (53)

1. S.D. Ramsey, B.R. Luce, R. Deyo, and G. Franklin The limited state of technology assessment for medical devices: facing the issues Am J Manag Care 4 Spec No(4) 1998 SP188 199
2. Rapport du Sénat, Le fonctionnement des comités consultatifs de protection des personnes dans la recherche biomédicale, Paris Available at http://www.senat.fr/rap/r00-267/r00-267.html 2001
3. Agence Franaise de Sécurité Sanitaire des Produits de Santé, Rapport annuel Available at http://www.afssaps.fr/var/afssaps- site/storage/original/application/11a395b6c25d1a12039513abea3f2eec.pdf 2007
4. G. Campbell Statistics in the world of medical devices: the contrast with pharmaceuticals J Biopharm Stat 18 2008 4 19
5. M.A. Konstam, I. Pina, J. Lindenfeld, and M. Packer A device is not a drug J Card Fail 9 2003 155 157
6. HAS opinions Available at http://www.has-sante.fr/portail/jcms/c-5267/ actes-produits-de-sante?cid=c-5267
7. D.L. Demets The role of surrogate outcome measures in evaluating medical devices Surgery 128 2000 379 385
8. P. McCulloch, I. Taylor, M. Sasako, B. Lovett, and D. Griffin Randomised trials in surgery: problems and possible solutions BMJ 324 2002 1448 1451
9. M.J. Solomon, C.K. Pager, J.M. Young, R. Roberts, and P. Butow Patient entry into randomized controlled trials of colorectal cancer treatment: factors influencing participation Surgery 133 2003 608 613
10. B.P. Hobbs, and B.P. Carlin Practical Bayesian design and analysis for drug and device clinical trials J Biopharm Stat 18 2008 54 80
11. G. Pennello, and L. Thompson Experience with reviewing Bayesian medical device trials J Biopharm Stat 18 2008 81 115
12. D.J. Spiegelhalter, L.S. Freedman, and M.K. Parmar Applying Bayesian ideas in drug development and clinical trials Stat Med 12 1993 1501 1511 discussion 13-17
13. D.J. Spiegelhalter, J.P. Myles, D.R. Jones, and K.R. Abrams Methods in health service research. An introduction to Bayesian methods in health technology assessment BMJ 319 1999 508 512
14. D.A. Berry A case for Bayesianism in clinical trials Stat Med 12 1993 1377 1393 discussion 95-404
15. D.A. Berry Introduction to Bayesian methods III: use and interpretation of Bayesian tools in design and analysis Clin Trials 2 2005 295 300 discussion 1-4, 64-78
16. D.A. Berry Bayesian clinical trials Nat Rev Drug Discov 5 2006 27 36
17. D. Malec, and J. Sedransk Bayesian predictive inference for units with small sample sizes. The case of binary random variables Med Care 31 5 Suppl 1993 YS66 YS70
18. W. Xiaoyin, C.Z. He, and S. Dongchu Bayesian population estimation for small sample capture-recapture data using noninformative priors J Stat Plan Inference 137 2007 1099 1118
19. R.J. Lewis, and R.L. Wears An introduction to the Bayesian analysis of clinical trials Ann Emerg Med 22 1993 1328 1336
20. G. Campbell The experience in the FDA's Center for Devices and Radiological Health with Bayesian strategies Clin Trials 2 2005 359 363 discussion 64-78
21. U.S. Food and Drug Administration. Guidance for the Use of Bayesian Statistics in Medical Device Clinical Trials. Center for Devices and Radiological Health, Division of Biostatistics, Office of Surveillance and Biometrics. Rockville,MD. February 5, 2010. Available at http://www.fda.gov/ downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ ucm071121.pdf
22. D.J. Spiegelhalter, J.P. Myles, D.R. Jones, and K.R. Abrams Bayesian methods in health technology assessment: a review Health Technol Assess 4 38 2000 1 130
23. The BaSiS Group Bayesian standards in science (BaSiS) Available at http://lib.stat.cmu.edu/bayesworkshop/2001/BaSis.html 2001
24. L. Sung, J. Hayden, M.L. Greenberg, G. Koren, B.M. Feldman, and G.A. Tomlinson Seven items were identified for inclusion when reporting a Bayesian analysis of a clinical study J Clin Epidemiol 58 2005 261 268
25. B. Lipscomb, G. Ma, and D.A. Berry Bayesian predictions of final outcomes: regulatory approval of a spinal implant Clin Trials 2 2005 325 333 discussion 34-39, 64-78
26. M.N. Babapulle, L. Joseph, P. Belisle, J.M. Brophy, and M.J. Eisenberg A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents Lancet 364 2004 583 591
27. J.M. Brophy, P. Belisle, and L. Joseph Evidence for use of coronary stents. A hierarchical Bayesian meta-analysis Ann Intern Med 138 2003 777 786
28. C.L. Grines, T.R. Nelson, R.D. Safian, G. Hanzel, J.A. Goldstein, and S. Dixon A Bayesian meta-analysis comparing AngioJet thrombectomy to percutaneous coronary intervention alone in acute myocardial infarction J Interv Cardiol 21 2008 459 482
29. S.K. Lam, and A. Owen Combined resynchronisation and implantable defibrillator therapy in left ventricular dysfunction: Bayesian network meta-analysis of randomised controlled trials BMJ 335 2007 925
30. S.R. Walsh, J.R. Boyle, A.G. Lynch, U. Sadat, J.P. Carpenter, and T.Y. Tang Suprarenal endograft fixation and medium-term renal function: systematic review and meta-analysis J Vasc Surg 47 2008 1364 1370
31. U.S. Food and Drug Administration Summary of safety and effectiveness data (P000028). AFFINITY Anterior Cervical Cage System Available at http://www.accessdata.fda.gov/cdrh-docs/pdf/P000028b.pdf June 13, 2002
32. U.S. Food and Drug Administration Summary of safety and effectiveness data (P000053). AMS Sphincter 800 Urinary Prosthesis Available at http://www.accessdata.fda.gov/cdrh-docs/pdf/P000053b.pdf June 14, 2001
33. U.S. Food and Drug Administration Summary of safety and effectiveness data (P980048). BAK/Cervical Interbody Fusion System Available at http://www.accessdata.fda.gov/cdrh-docs/pdf/P980048b.pdf April 20, 2001
34. U.S. Food and Drug Administration Summary of safety and effectiveness (P080007). Bard E-LUMINEXX Vascular Stent Available at http://www.accessdata. fda.gov/cdrh-docs/pdf8/P080007b.pdf December 4, 2008
35. U.S. Food and Drug Administration Summary of safety and effectiveness data (P060023). BRYAN Cervical Disc Available at http://www.accessdata.fda.gov/ cdrh-docs/pdf6/P060023b.pdf July 17, 2009
36. U.S. Food and Drug Administration Summary of safety and effectiveness data (P000036). DERMAGRAFT Available at http://www.accessdata.fda.gov/cdrh-docs/ pdf/P000036b.pdf September 28, 2001
37. U.S. Food and Drug Administration Summary of safety and effectiveness data (P040021). Epic Valve Available at http://www.accessdata.fda.gov/cdrh-docs/ pdf4/P040021b.pdf November 15, 2007
38. U.S. Food and Drug Administration Summary of safety and effectiveness data (P020014). Essure System Available at http://www.accessdata.fda.gov/cdrh- docs/pdf2/P020014b.pdf November 4, 2002
39. U.S. Food and Drug Administration Summary of safety and effectiveness data (P000058). InFUSE Bone Graft/LT-CAGE Lumbar Tapered Fusion Device Available at http://www.accessdata.fda.gov/cdrh-docs/pdf/P000058b.pdf July 2, 2002
40. U.S. Food and Drug Administration Summary of safety and effectiveness data (P970015). Intervertebral body fusion device, INTER FIX Threated Fusion Device Available at http://www.accessdata.fda.gov/cdrh-docs/pdf/P970015b.pdf May 14, 1999
41. FDA-Prestige U.S. Food and Drug Administration Summary of safety and effectiveness data (P060018). PRESTIGE Cervical Disc System Available at http://www.accessdata.fda.gov/cdrh-docs/pdf6/P060018b.pdf July 16, 2007
42. U.S. Food and Drug Administration Summary of safety and effectiveness data (P040021). SJM Biocor Valve Available at http://www.accessdata.fda.gov/ cdrh-docs/pdf4/P040021b.pdf August 5, 2005
43. J.P. Higgins, and A. Whitehead Borrowing strength from external trials in a meta-analysis Stat Med 15 1996 2733 2749
44. T.C. Prevost, K.R. Abrams, and D.R. Jones Hierarchical models in generalized synthesis of evidence: an example based on studies of breast cancer screening Stat Med 19 2000 3359 3376
45. A.J. Sutton, and K.R. Abrams Bayesian methods in meta-analysis and evidence synthesis Stat Methods Med Res 10 2001 277 303
46. A.J. Sutton, K.R. Abrams, D.R. Jones, T.A. Sheldon, and F. Song Systematic reviews of trials and other studies Health Technol Assess 2 19 1998 1 276
47. D.N. Wijeysundera, P.C. Austin, J.E. Hux, W.S. Beattie, and A. Laupacis Bayesian statistical inference enhances the interpretation of contemporary randomized controlled trials J Clin Epidemiol 62 2009 13 21 e5
48. L.D. Fisher Comments on Bayesian and frequentist analysis and interpretation of clinical trials Control Clin Trials 17 1996 423 434
49. M.K. Parmar, D.J. Spiegelhalter, and L.S. Freedman The CHART trials: Bayesian design and monitoring in practice. CHART Steering Committee Stat Med 13 1994 1297 1312
50. R.J. Lilford Ethics of clinical trials from a Bayesian and decision analytic perspective: whose equipoise is it anyway? BMJ 326 2003 980 981
51. R.J. Lilford, and J. Jackson Equipoise and the ethics of randomization J R Soc Med 88 1995 552 559
52. M.D. Cowles, and B.P. Carlin Markov Chain Monte Carlo convergence diagnostics: a comparative review J Am Stat Assoc 91 1996 883 904
53. S. Van Dongen Prior specification in Bayesian statistics: three cautionary tales J Theor Biol 242 2006 90 100